Hanseatic Management Services’s Intercept Pharmaceuticals, Inc. ICPT Stock Holding History

Hanseatic Management Services’s Portfolio ICPT Stock Details ICPT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-274	Closed	-$4K	–	148
2023 Q1	$4K	Buy	+274	New	+$4.74K	0.01%	106
2020 Q1	–	Sell	-93	Closed	-$12K	–	284
2019 Q4	$12K	Buy	+93	New	+$8.33K	0.01%	186
2019 Q2	–	Sell	-2,077	Closed	-$232K	–	285
2019 Q1	$232K	Buy	2,077 +224	+12%	+$24.5K	0.24%	102
2018 Q4	$187K	Sell	1,853 -212	-10%	-$22K	0.25%	96
2018 Q3	$261K	Buy	+2,065	New	+$219K	0.24%	104

Other funds holding ICPT

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Caligan Partners New York $1.5B AUM 518.95% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

PAMS

Pictet Asset Management (Switzerland) Geneva 73, Switzerland $84.3B AUM 26.5% 1-Year Est. Return

BFM

Boothbay Fund Management New York $7.71B AUM 106.31% 1-Year Est. Return

DCM

DG Capital Management New York $326M AUM 39.67% 1-Year Est. Return

Hanseatic Management Services's ICPT Position: Q2 2023 in Review

Hanseatic Management Services sold out of Intercept Pharmaceuticals, Inc. (ICPT) in Q2 2023, closing a stake of 274 shares — an estimated $4K sold.

Hanseatic Management Services first reported a position in ICPT in Q3 2018 and held it in 5 quarters. The position peaked at $261K in Q3 2018. 126 funds tracked by Wall St. Rank hold ICPT as of Q2 2023.

Hanseatic Management Services reported no remaining Intercept Pharmaceuticals, Inc. position as of Q2 2023 after selling out during the quarter.
Hanseatic Management Services sold 274 Intercept Pharmaceuticals, Inc. shares in Q2 2023, an estimated $4K.
Hanseatic Management Services first reported a position in Intercept Pharmaceuticals, Inc. in Q3 2018 and held it in 5 quarters.
Hanseatic Management Services's Intercept Pharmaceuticals, Inc. position peaked at $261K in Q3 2018.
126 funds tracked by Wall St. Rank held Intercept Pharmaceuticals, Inc. as of Q2 2023.

Based on Hanseatic Management Services's 13F filing for Q2 2023, filed 26 Jul 2023.